Co-Authors
This is a "connection" page, showing publications co-authored by Chong Yu and Chih-Cheng Lai.
Connection Strength
0.717
-
Risk of Sepsis and Mortality Among Patients With Chronic Obstructive Pulmonary Disease Treated With Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers. Crit Care Med. 2019 01; 47(1):e14-e20.
Score: 0.201
-
Comparative effects of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on the risk of pneumonia and severe exacerbations in patients with COPD. Int J Chron Obstruct Pulmon Dis. 2018; 13:867-874.
Score: 0.190
-
Severe exacerbation and pneumonia in COPD patients treated with fixed combinations of inhaled corticosteroid and long-acting beta2 agonist. Int J Chron Obstruct Pulmon Dis. 2017; 12:2477-2485.
Score: 0.182
-
The Impact of Sepsis on the Outcomes of COPD Patients: A Population-Based Cohort Study. J Clin Med. 2018 Oct 27; 7(11).
Score: 0.050
-
Risks of Pneumonia in COPD Patients with New-Onset Atrial Fibrillation. J Clin Med. 2018 Aug 21; 7(9).
Score: 0.049
-
Impact of selective and nonselective beta-blockers on the risk of severe exacerbations in patients with COPD. Int J Chron Obstruct Pulmon Dis. 2017; 12:2987-2996.
Score: 0.046